342 top medical experts on Facioscapulohumeral Muscular Dystrophy across 28 countries and 27 U.S. states, including 191 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.

  1. Facioscapulohumeral Muscular Dystrophy: An autosomal dominant degenerative muscle disease characterized by slowly progressive weakness of the muscles of the face, upper-arm, and shoulder girdle. The onset of symptoms usually occurs in the first or second decade of life. Affected individuals usually present with impairment of upper extremity elevation. This tends to be followed by facial weakness, primarily involving the orbicularis oris and orbicularis oculi muscles. (Neuromuscul Disord 1997;7(1):55-62; Adams et al., Principles of Neurology, 6th ed, p1420)
  2. Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
  3. Broader Categories (#Experts): Muscular Dystrophies (1,543).
  4. Clinical Trials ClinicalTrials.gov : at least 47 including 5 Active, 22 Completed, 10 Recruiting
  5. Synonyms: Landouzy-Dejerine Dystrophy


  

        

                    


    Computing Expert Listing ...

);